ArticleResearch square2026
The Effect of a Global Health Shock on Preventive Drug Intake: Evidence from SHARE 2020-2022 for 15 European Countries.
Article in Research square, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
Abstract
Self-medication is known to have potential harmful consequences. In times of a health shock, like the COVID-19 pandemic, preventive drug intake may imply irresponsible behaviour. To provide insight into this phenomenon, this study explores the preventive behaviour of 4,642 respondents of the Survey of Health, Ageing and Retirement in Europe (SHARE) for the period 2020-2022 and 15 European countries. It aims at highlighting relevant drivers and relies on an econometric analysis backed by random-effects panel logistic as well as pooled logistic estimators. The results indicate that being female, more educated, with income, in worse health, or out of work due to COVID-19 relates to higher odds of using preventive drugs for COVID-19 disease. Interaction effects illustrate that those who report symptoms are additionally more likely to take preventive drugs when in poor health, with income, or having hardly any difficulties with making ends meet. Surprisingly, preventive drug intake when reporting symptoms decreases at older ages. No relevant impact is found for relationship status, financial distress, and country of citizenship. Overall, the study identifies important drivers of preventive drug intake informative for policymaking in the context of a health shock like COVID-19.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.